Scripta Therapeutics operates as a bio-tech company.
Scripta Therapeutics has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Scripta Therapeutics's investors include YZR Capital, Oxford Science Enterprises, Parkwalk Advisors, AlbionVC, Apollo Health Ventures.
Scripta Therapeutics is headquartered in Oxford, United Kingdom.
Scripta Therapeutics operates as a bio-tech company.
Scripta Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scripta Therapeutics — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/scripta-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Scripta Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/scripta-therapeutics
{{cite web |title=Scripta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scripta-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated